These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25816979)

  • 1. Nanotechnology approaches for antibacterial drug delivery: Preparation and microbiological evaluation of fusogenic liposomes carrying fusidic acid.
    Nicolosi D; Cupri S; Genovese C; Tempera G; Mattina R; Pignatello R
    Int J Antimicrob Agents; 2015 Jun; 45(6):622-6. PubMed ID: 25816979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria.
    Nicolosi D; Scalia M; Nicolosi VM; Pignatello R
    Int J Antimicrob Agents; 2010 Jun; 35(6):553-8. PubMed ID: 20219328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.
    Zhang L; Benz R; Hancock RE
    Biochemistry; 1999 Jun; 38(25):8102-11. PubMed ID: 10387056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).
    Biedenbach DJ; Rhomberg PR; Mendes RE; Jones RN
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):301-7. PubMed ID: 20159376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antibacterial activity of cinnamon oil on the selected gram-positive and gram-negative bacteria].
    Urbaniak A; Głowacka A; Kowalczyk E; Lysakowska M; Sienkiewicz M
    Med Dosw Mikrobiol; 2014; 66(2):131-41. PubMed ID: 25369660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
    Stefani S; Debbia EA; Schito GC; Russo G
    Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria.
    Kuwano K; Tanaka N; Shimizu T; Nagatoshi K; Nou S; Sonomoto K
    Int J Antimicrob Agents; 2005 Nov; 26(5):396-402. PubMed ID: 16226432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
    Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
    J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial effects of poly(2-(dimethylamino ethyl)methacrylate) against selected gram-positive and gram-negative bacteria.
    Rawlinson LA; Ryan SM; Mantovani G; Syrett JA; Haddleton DM; Brayden DJ
    Biomacromolecules; 2010 Feb; 11(2):443-53. PubMed ID: 20025269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoinactivation of Gram positive and Gram negative bacteria with the antimicrobial peptide (KLAKLAK)(2) conjugated to the hydrophilic photosensitizer eosin Y.
    Johnson GA; Muthukrishnan N; Pellois JP
    Bioconjug Chem; 2013 Jan; 24(1):114-23. PubMed ID: 23240991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-aqueous glycerol monolaurate gel exhibits antibacterial and anti-biofilm activity against Gram-positive and Gram-negative pathogens.
    Mueller EA; Schlievert PM
    PLoS One; 2015; 10(3):e0120280. PubMed ID: 25799455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance analysis of bacterial strains isolated from burn patients.
    Wang LF; Li JL; Ma WH; Li JY
    Genet Mol Res; 2014 Jan; 13(4):9727-34. PubMed ID: 24535909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.